Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation
- 1 September 2000
- journal article
- Published by Elsevier
- Vol. 48 (5) , 381-388
- https://doi.org/10.1016/s0006-3223(00)00918-5
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in RatsScience, 1998
- Schizophrenia: A neural diathesis-stress model.Psychological Review, 1997
- Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
- The Effects of AMPA‐induced Lesions of the Medial Septum and Vertical Limb Nucleus of the Diagonal Band of Broca on Spatial Delayed Non‐matching to Sample and Spatial Learning in the Water MazeEuropean Journal of Neuroscience, 1995
- Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: Implications for cholinergic-based therapiesLife Sciences, 1995
- Clozapine is a potent and selective muscarinic M4 receptor agonistEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampusHippocampus, 1993
- Muscarinic Receptor SubtypesAnnual Review of Pharmacology and Toxicology, 1990
- Cholinergic innervation of the rat hippocampus as revealed by choline acetyltransferase immunocytochemistry: A combined light and electron microscopic studyJournal of Comparative Neurology, 1985
- SCHIZOPHRENIA AND THE LIMBIC SYSTEMThe Lancet, 1974